Assessment of the Safety and Effectiveness of Stem Cell Treatments for Dry Eye Syndrome Associated with Sjögren’s Syndrome: A Systematic Review and Meta-Analysis - Top-Institutions - MDSpire

Assessment of the Safety and Effectiveness of Stem Cell Treatments for Dry Eye Syndrome Associated with Sjögren’s Syndrome: A Systematic Review and Meta-Analysis

  • By

  • Jizhong Zhang

  • Wenshuang Wang

  • Changyong Li

  • April 29, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute, University of Miami
    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Cornea and External Disease
    • Regenerative Medicine

  • #2

    Massachusetts Eye and Ear Infirmary, Harvard Medical School
    Massachusetts Eye and Ear Infirmary, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Immunology
    • Stem Cell Research

  • #3

    Schepens Eye Research Institute, Harvard Medical School
    Schepens Eye Research Institute, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Stem Cell Biology
    • Autoimmune Disease

  • #4

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Regenerative Medicine
    • Autoimmune Disorders

  • #5

    Moorfields Eye Hospital and UCL Institute of Ophthalmology
    Moorfields Eye Hospital and UCL Institute of Ophthalmology

    London, N/A

    Key Differentiators

    • Ophthalmology
    • Stem Cell Therapy
    • Autoimmune Eye Disease

Original Source(s)

Assessment of the Safety and Effectiveness of Stem Cell Treatments for Dry Eye Syndrome Associated with Sjögren’s Syndrome: A Systematic Review and Meta-Analysis

  • by Jizhong Zhang, Wenshuang Wang, Changyong Li

  • April 29, 2026

Related Content

Comparative study of the therapeutic effects of different medications on DM-associated dry eye syndrome after vitrectomy

Association of Age and Ocular Surface Parameters with Morphological Alterations in Meibomian Glands

CSO Meeting 2026 Highlights Convergence of Innovation and Clinical Practice

More than 300 professionals gathered for three days of innovation, education, and collaboration, highlighting the latest advances in ophthalmic technology and clinical practice

  • May 12, 2026

  • 2 min